Potassium citrate and Sabril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium citrate (potassium citrate) and Sabril (vigabatrin). Common drug interactions include abdominal pain among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium citrate and Sabril. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium citrate?

Potassium citrate has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 5,909 Potassium citrate users. Check the latest studies of Potassium citrate.

What is Sabril?

Sabril has active ingredients of vigabatrin. eHealthMe is studying from 12,445 Sabril users. Check the latest studies of Sabril.

On Jul, 12, 2026

15 people who take Potassium citrate and Sabril together, and have interactions are studied.

Potassium citrate and Sabril drug interactions.

What are the common drug interactions of Potassium Citrate and Sabril, by gender? *:

female:

Abdominal pain
Acidosis (build-up of carbon dioxide in the blood)
Drug ineffective
Ear infection
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
Pneumonia
Respiratory syncytial virus infection (viral disease of respiratory system)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)

male:

Asthma
Constipation
Secondary hypertension (elevated blood pressure that results from an underlying, identifiable, often correctable cause)
Somnolence (a state of near-sleep, a strong desire for sleep)
Death
Viral infection
Dyspepsia (indigestion)
Oral discharge
Pneumonia
Upper respiratory tract inflammation

What are the common drug interactions of Potassium Citrate and Sabril, by age (0-1 to 60+)? *:

0-1:

Diarrhoea
Drug ineffective
Hypokalaemia (low potassium)
Secondary hypertension (elevated blood pressure that results from an underlying, identifiable, often correctable cause)
Viral infection

2-9:

Asthma
Acidosis (build-up of carbon dioxide in the blood)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Constipation
Dyspepsia (indigestion)
Oral discharge
Pneumonia
Upper respiratory tract inflammation
Gastritis (inflammation of stomach)

10-19:

Somnolence (a state of near-sleep, a strong desire for sleep)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Death

60+:

n/a

What are the existing conditions these people have? *

Infantile Spasms: 10 people, 66.67%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 5 people, 33.33%
Asthma: 5 people, 33.33%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 20.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 13.33%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 6.67%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 6.67%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 1 person, 6.67%
Acidosis (build-up of carbon dioxide in the blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium citrate and Sabril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously